troglitazone has been researched along with Left Ventricular Hypertrophy in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the effects of troglitazone, an agent used to treat insulin resistance, on cardiac sympathetic nervous dysfunction and insulin resistance in patients with essential hypertension." | 9.11 | Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension. ( Hamada, M; Ikeda, S; Inaba, S; Kohara, K; Komatsu, J; Kurata, M; Sueda, S; Suzuki, J; Watanabe, K, 2004) |
| "To examine the effects of troglitazone, an agent used to treat insulin resistance, on cardiac sympathetic nervous dysfunction and insulin resistance in patients with essential hypertension." | 5.11 | Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension. ( Hamada, M; Ikeda, S; Inaba, S; Kohara, K; Komatsu, J; Kurata, M; Sueda, S; Suzuki, J; Watanabe, K, 2004) |
| "Patients with NIDDM have excessive cardiovascular morbidity and mortality, even in the absence of hypertension." | 1.31 | Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients. ( Abe, N; Hirayama, H; Makino, N; Sugano, M; Yonemoch, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, K | 1 |
| Komatsu, J | 1 |
| Kurata, M | 1 |
| Inaba, S | 1 |
| Ikeda, S | 1 |
| Sueda, S | 1 |
| Suzuki, J | 1 |
| Kohara, K | 1 |
| Hamada, M | 1 |
| Hirayama, H | 1 |
| Sugano, M | 1 |
| Abe, N | 1 |
| Yonemoch, H | 1 |
| Makino, N | 1 |
1 trial available for troglitazone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension.
Topics: Antihypertensive Agents; Blood Glucose; Chromans; Female; Heart; Humans; Hypertension; Hypertrophy, | 2004 |
1 other study available for troglitazone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients.
Topics: Blood Flow Velocity; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chromans; | 2001 |